Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$10.0 - $21.64 $23,900 - $51,719
-2,390 Closed
0 $0
Q1 2024

May 14, 2024

SELL
$9.3 - $13.23 $5,487 - $7,805
-590 Reduced 24.69%
1,800 $23,000
Q4 2023

Aug 05, 2024

BUY
$8.1 - $16.36 $4,779 - $9,652
590 Added 32.78%
2,390 $26,000
Q3 2023

Nov 01, 2023

BUY
$14.03 - $22.08 $33,531 - $52,771
2,390 New
2,390 $34,000
Q2 2022

Aug 05, 2022

BUY
$5.75 - $7.74 $10,350 - $13,932
1,800 New
1,800 $13,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $839M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Stonehage Fleming Financial Services Holdings LTD Portfolio

Follow Stonehage Fleming Financial Services Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonehage Fleming Financial Services Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Stonehage Fleming Financial Services Holdings LTD with notifications on news.